intake

2 trials

Sponsors

The Affiliated Drum Tower Hospital of Nanjing University Medical School, PET-CT Center, Affiliated Cancer Hospital of Zhengzhou University

Conditions

PA-HSOStumor

Early Phase 1

Clinical application of new imaging agent Al [18F]-FAPI-04 in tumor

RecruitingChiCTR2100048334

PET-CT Center, Affiliated Cancer Hospital of Zhengzhou Universitytumor

Start: 2021-07-01Updated: 2022-03-14

Unknown Phase

Diagnostic value of “Nanjing Criteria” for patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome:a diagnoctic test.

RecruitingChiCTR1900020784

The Affiliated Drum Tower Hospital of Nanjing University Medical SchoolPA-HSOS

Start: 2019-01-16Updated: 2019-01-28

Related Papers

Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome.

2021-03-3113 citations